Substance
SODIUM OXYBATE
Global reference: every product and company linked to this substance.
- cas: 502-85-2
- ncit: C61870
- pubchem_cid: 23663870
- rxnorm: 9899
- unii: 7G33012534
CATABATE · LUMRYZ · NSC-84223 · Oxybate sodium [WHO-DD] · SODIUM OXYBATE [USAN] · WY-3478 · XYREM · XYWAV COMPONENT SODIUM OXYBATE
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC COMMON STOCK (IRELAND) | XYWAV | Q2 2026 | $471.2M* |
| JAZZ PHARMACEUTICALS PLC COMMON STOCK (IRELAND) | XYREM | Q2 2026 | $30.5M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- SODIUM OXYBATE · AMNEAL PHARMACEUTICALS INC. CLASS A COMMON STOCK
- XYREM · JAZZ PHARMACEUTICALS PLC COMMON STOCK (IRELAND)
- XYWAV · JAZZ PHARMACEUTICALS PLC COMMON STOCK (IRELAND)